Investigations on the Effect of Kale on the Lipid Status
- Conditions
- Effects of Kale Ingredients on Lipid Status Parameter
- Interventions
- Dietary Supplement: Kale Preparation "Kale Powder"Dietary Supplement: Kale Preparation "Kale Extract"Dietary Supplement: Kale Preparation "Flavonoid Extract"Dietary Supplement: Placebo
- Registration Number
- NCT03545555
- Lead Sponsor
- University of Jena
- Brief Summary
This intervention study investigates the effects of various kale preparations (dietary supplements) on lipid status parameters. Within the study period of 8 weeks, three blood withdrawals are planned (week 0, 4 and 8) for the volunteers. Lipid status parameters (total cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerides) will be determined in blood. There is a correlation between contents of LDL cholesterol, total cholesterol and triacylglycerides and the risk for cardiovascular diseases (CVD). In contrast, a high content of HDL cholesterol is correlated with a lower risk for CVD. In addition, the contents of apolipoprotein A1 and apolipoprotein B will be analysed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 40
- total cholesterol > 200 mg/dl
- LDL cholesterol < 130 mg/dl
- medication to lower blood lipids
- genetically based hypercholesterolemia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Kale Powder Kale Preparation "Kale Powder" 5 capsules with kale preparation "kale powder" per day for 8 weeks Kale Extract Kale Preparation "Kale Extract" 5 capsules with kale preparation "kale extract" per day for 8 weeks Flavonoid Extract Kale Preparation "Flavonoid Extract" 5 capsules with kale preparation "flavonoid extract" (from kale) per day for 8 weeks Placebo Placebo 5 capsules with "placebo" per day for 8 weeks
- Primary Outcome Measures
Name Time Method Change of lipid status parameters weeks 0, 4 and 8 total cholesterol, HDL cholesterol, LDL cholesterol
- Secondary Outcome Measures
Name Time Method Change of apolipoproteins weeks 0, 4 and 8 apolipoprotein A1 and apolipoprotein B
Change of antioxidant capacity weeks 0, 4 and 8 lipophilic antioxidant capacity (L-TEAC)
Trial Locations
- Locations (1)
Friedrich Schiller University, Institute iof Nutritional Science
🇩🇪Jena, Thuringia, Germany